Incentive stock plans and stock-based compensation | 9. Incentive stock plans and stock-based compensation Common stock options The Company adopted a stock-based compensation plan for employees and non-employee members of its Board of Directors in November 2003 (the “2003 Plan”), and the National Patent Development Corporation 2007 Incentive Stock Plan in December 2007 (the “2007 NPDC Plan”). The periods during which additional awards may be granted under the plans have expired and no further awards may be granted under any of these plans after December 20, 2017. As a consequence, any equity compensation awards issued after that time will be on terms determined by the Board of Directors or the Compensation Committee of the Board of Directors and pursuant to exemptions from the registration requirements of the securities laws. The Company recorded compensation expense of $0 and $100, respectively, for the three ended June 30, 2019 and 2018, respectively, under these plans and compensation expense of $0 and $100, respectively, the six months ended June 30, 2019 and 2018, respectively, under these plans. The Company issued 100,000 options to a consultant on March 28, 2016 which vest equally over 3 years and are subject to post vesting restrictions for sale for three years with an exercise price of $1.29, which price was equal to the market value at the date of the grant. The fair value of the options granted on March 28, 2016 were reduced by an 8% discount for post vesting restrictions. As of June 30, 2019, all options were vested and there were outstanding options to acquire 550,000 common shares under the 2007 NPDC Plan. All 550,000 options were vested and exercisable, having a weighted average exercise price of $1.35 per share, a weighted average contractual term of 1.75 years and zero aggregate intrinsic value. There were no grants, forfeitures or options exercised during the first and second quarters of 2019 and 2018, respectively. Restricted stock units On January 19, 2015 and March 31, 2015, 100,000 restricted stock units (“RSUs”) were issued on each date to two newly appointed directors of the Company. The RSUs vested equally over 3 years. The RSUs are valued based on the closing price of the Company’s common stock on January 19, 2015 and March 31, 2015 of $1.70 and $1.85, respectively, less an average discount of 8% for post-vesting restrictions on sale until the three-year anniversary of the grant date, or an average price per share of $1.56 and $1.70, respectively. As of June 30, 2019, and 2018, the RSU’s were already fully vested and the related 200,000 shares of the Company’s common stock were issued during the year ended December 31, 2018. On February 13, 2019, 100,000 restricted stock units (“RSUs”) were issued to a newly appointed director of the Company. The RSUs vest equally, annually, over 3 years. The RSUs are valued based on the closing price of $0.42 of the Company’s common stock on February 13, 2019, less an average discount of 8% for post-vesting restrictions on sale until the three-year anniversary of the grant date, or an average price per share of $0.39. The Company recorded compensation expense of $4,000 and $16,000 for the six months ended June 30, 2019 and 2018, respectively, related to these RSUs. The total unrecognized compensation expense related to these unvested RSUs at June 30, 2019 is $35,000, which will be recognized over the remaining vesting period of approximately 2.5 years. |